is wegovy a glp-1 Comparing Ozempic, and Other Drugs Quit a GLP-1? Plan to

Overall, all 5 studies displayed a low risk of bias

[DOI] [PubMed] [Google Scholar] 13.Van de Wiele VL, Kesselheim AS, Beran D, Darrow JJ

2 For a complete list of potential side effects, visit: What happens if you miss a dose of GLP-1

#GLP1 #Pharma #Strategy #MarketAccess #PharmaGambit To view or add a comment, sign in AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS VESALIUS-CV Subgroup Results Show Repatha Reduces Risk of First Major Cardiovascular Events by 29% in People Living with High-Risk Diabetes New Real-World Data Highlight Treatment Gaps in Current Obesity and Diabetes Care THOUSAND OAKS, Calif., [...] #LosAngeles #OrangeCountyCA #Biotech #Lifescience #News To view or add a comment, sign in AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS VESALIUS-CV Subgroup Results Show Repatha Reduces Risk of First Major Cardiovascular Events by 29% in People Living with High-Risk Diabetes New Real-World Data Highlight Treatment Gaps in Current Obesity and Diabetes Care THOUSAND OAKS, Calif., [...] To view or add a comment, sign in Imagine telling a pharmacist in 2015: A diabetes drug will soon be used for weight loss, heart protection, kidney disease, fatty liver disease, and even sleep apnea. Most people would have laughed

Even less is known about how these reasons differ between those using GLP-1 RAs as anti-obesity medications (AOMs) versus those using them for antidiabetic management (ADMs), or how these patterns have changed over time as awareness, access, and prescribing practices have evolved